Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

What a 38-year study suggests about red meat, white meat, and mortality

18

Aug 2026

What a 38-year study suggests about red meat, white meat, and mortality

Lower intake of red and processed meat was associated with small reductions in all-cause, heart disease, cancer, and stroke mortality in a cohort of nearly one million US adults followed for decades. White-meat-only diets showed additional benefits in some subgroups, while vegetarian diets produced few consistent associations and were limited by small participant numbers and a single baseline dietary assessment.

Whole grains, legumes and vegetables stand out in a major review of diabetes diets

18

Aug 2026

Whole grains, legumes and vegetables stand out in a major review of diabetes diets

Healthy plant-based diets rich in whole grains, legumes, fruits, vegetables, nuts, and seeds are associated with better glycemic control and a lower risk of type 2 diabetes. The review finds that food quality and processing matter more than simply avoiding animal foods, while unhealthy plant-based patterns and higher red and processed meat intake are associated with greater metabolic risk.

A New York skincare survey found mercury where consumers might not expect it

18

Aug 2026

A New York skincare survey found mercury where consumers might not expect it

Targeted surveillance of 197 skin-lightening and skincare products purchased in New York City from 2009 to 2022 found detectable mercury in 29%, with 18% exceeding the FDA’s 1 ppm limit and concentrations reaching 27,000 ppm. All mercury-positive products were manufactured abroad, mercury was rarely disclosed on labels, and the findings highlight regulatory, health-equity, and environmental justice concerns.

A four-week spice experiment challenges expectations about post-meal benefits

17

Aug 2026

A four-week spice experiment challenges expectations about post-meal benefits

Culinary doses of herbs and spices did not significantly alter postprandial endothelial function, glycemia, or lipemia after four weeks of corresponding spice-containing diets in adults at cardiometabolic risk. The findings suggest that acute spice-related effects may be less apparent with longer-term exposure, although the study may have been underpowered to detect modest benefits.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.